Each of these situations is discussed in Appendix 1.

Similar documents
Oklahoma Facts CPT. Definitions. Mohs Micrographic Surgery. What Does That Mean? Billing and Coding for Mohs Surgery

OBJECTIVES By the end of this segment, the community participant will be able to:

How to treat early gastric cancer. Surgery

The Diagnosis of Cancer in the Pathology Laboratory

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

An individual is considered an incident case only once per lifetime.

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

BREAST CANCER PATHOLOGY

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Probe: Could you tell me about when?

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

THYROID CANCER. I. Introduction

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Melanoma of Skin. Overview. This webinar is sponsored by

Coding Dermatology Procedures. Presented by: Betty A Hovey Director, ICD-10 Development and Training AAPC

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

Contents. Updated July 2011

Kidney Cancer OVERVIEW

Frozen Section Diagnosis

Understanding your pathology report

Understanding Your Surgical Options For Breast Cancer

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Cervical Cancer The Importance of Cervical Screening and Vaccination

METROPOLITAN LIFE INSURANCE COMPANY NEW YORK, NEW YORK

A918: Prostate: adenocarcinoma

September 5, Linda Stewart Vice President, National Lab Program UnitedHealthcare Group P.O. Box 1459 Minneapolis, MN

Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE

Your Guide to the Breast Cancer Pathology Report

Melanoma The Skin Understanding Cancer

Guide to Understanding Breast Cancer

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

How to report Upper GI EMR/ESD specimens

Breast. Patient information. cancer clinical pathway

Prostate Cancer. Treatments as unique as you are

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Corporate Medical Policy

Report series: General cancer information

Update on Mesothelioma

Male. Female. Death rates from lung cancer in USA

A PATIENT S GUIDE TO ABLATION THERAPY

Customer Satisfaction in Anatomic Pathology. A College of American Pathologists Q-Probes Study of 3065 Physician Surveys From 94 Laboratories

Your Guide to Express Critical Illness Insurance Definitions

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

YOUR LUNG CANCER PATHOLOGY REPORT

COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina

ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival

Squamous Cell Carcinoma of Anal Canal Treatment Guidelines

Ductal carcinoma in situ (DCIS)

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL

The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006

IBCSG Tissue Bank Policy

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Cancer 1000 Level 2 Benefit Chart and Outline of Coverage

COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina

why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3

III II II III. ge: /ears sex: Male Access

Disclaimer CODING 101 BOOT CAMP CODING SEMINAR FOR NEW PHYSICIANS

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide

Technology Assisting Cancer Outcomes: Automated Biomarker Abstraction Overcoming Textual Data-Silos

Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma

Description of Procedure or Service. assays_of_genetic_expression_to_determine_prognosis_of_breast_cancer 11/2004 3/2015 3/2016 3/2015

Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer

Together, The Strength

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds

Understanding Metastatic Disease

Explanation of your PAP smear

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?

Error Reduction and Prevention in Surgical Pathology. Raouf E. Nakhleh, MD Professor of Pathology Mayo Clinic Florida

Corporate Overview. April 2014 OTCQB: LCDX

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

PATHOLOGY DEPARTMENTS AT GRADUATE MEDICAL EDUCATION TEACHING INSTITUTIONS

Cancer Care Delivered Locally by Physicians You Know and Trust

COLONIAL LIFE & ACCIDENT INSURANCE COMPANY 1200 Colonial Life Boulevard, P. O. Box 1365 Columbia, South Carolina (800)

The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options

Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW

Post-PET Restaging Cancer Form National Oncologic PET Registry

Cancer of the Cardia/GE Junction: Surgical Options

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

Innovations in Kidney Cancer

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES

Breast Cancer. The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer.

SQUAMOUS CELL CARCINOMA

An Introduction to PROSTATE CANCER

Integumentary System Individual Exercises

Re: Horizon Blue Cross Blue Shield of New Jersey Inappropriate Application of Modifier 25

How CanCer becomes critical in the claims

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)

Early Prostate Cancer: Questions and Answers. Key Points

Conversion to NAACCR 13

Lesions, and Masses, and Tumors Oh My!!

PLASTIC SURGERY RESIDENTS HANDBOOK

Mohs Micrographic Surgery

Breakthrough Treatment Options for Breast Cancer

Captivator EMR Device

Monitoring customer satisfaction is an important and

Transcription:

Position Statement on Appropriate Uses of Paraffin Sections in Association with Mohs Micrographic Surgery (Approved by the Board of Directors ) According to AMA/CPT, Mohs micrographic surgery is a technique for the removal of complex or ill-defined skin cancer with histologic examination of 100% of the surgical margins. It requires a single physician to act in two integrated but separate and distinct capacities: surgeon and pathologist. If either of these responsibilities is delegated to another physician who reports the services separately, these codes should not be reported. The Mohs surgeon removes the tumor tissue and maps and divides the tumor specimen into pieces, and each piece is embedded into an individual tissue block for histopathologic examination. This paper is not intended to contradict this description of Mohs surgery; however, it addresses the issue of rare and infrequent circumstances when the physician performing the Mohs surgery may need to obtain a second pathologic opinion. When Pathology Consultation or Paraffin Sections are Compatible with Mohs Surgery Mohs surgery with frozen section tissue processing is highly effective for the delineation of tumor margins. In a small minority of cases, further paraffin (formalin-fixed) section pathologic evaluation may be necessary for optimal patient care. This may occur before, during, or after the Mohs procedure. Examples include, but are not limited to, the following: (1) A second opinion consultation is required during surgical treatment of melanoma; (2) Further tissue processing is required to assess features of an aggressive, deep or histologically unusual tumor; (3) Paraffin section evaluation is used to confirm a diagnosis other than what was found on a prior pathology report, upon which Mohs surgery was done; (4) Further tissue analysis is necessary to complete the staging of a tumor so that the need for additional therapy, such as radiation or chemotherapy, can be determined; (5) Unusual findings during frozen section evaluation, or during other portions of the Mohs case, lead the physician to conclude that a second pathologic opinion is necessary. (6) Despite proper processing technique, frozen section interpretation is not sufficient to assess the tissue margin with a high degree of reliability. (7) A biopsy specimen of tumor not previously biopsied is obtained and assessed by frozen section immediately before commencement of Mohs, the pathologic diagnosis is then confirmed by paraffin section. Each of these situations is discussed in Appendix 1.

Page 2 of 6 Criteria for Mohs Surgery are Not Met In certain circumstances, sending paraffin sections for pathologic evaluation is not compatible with Mohs surgery. In general, this occurs when one or more of the tasks that must be performed by the operating surgeon are delegated to another physician. (1) When all specimens removed during the course of Mohs are sent to a pathologist for interpretation of paraffin sections, then Mohs is no longer being performed. Instead, the physician removing the tissue should characterize that process as an excision and document it as such. (2) When a separate physician, such as a pathologist, reads all the slides made from tissue removed by the physician during a particular stage of Mohs surgery, this will constitute delegation of responsibility and as such, makes it incompatible with Mohs surgery. This differs from the permissible case where, during a particular stage of Mohs surgery, the physician obtains and processes all the tissue, and reads all of the slides for margin assessment, but then obtains additional second opinion pathologic consultation on a portion of these slides. (3) Routine review of histopathlogic features of a tumor being treated with Mohs by a pathologist is not compatible with Mohs surgery. In general, pathologic consultation should occur in a rare number of cases. For additional information on meeting the criteria for Mohs, see Appendix 2. Conclusions In most cases when Mohs surgery is performed, no tissue specimen is sent for paraffin sectioning and pathologic assessment. However, infrequently, it is appropriate (before, during or after) to send tissue for paraffin sections and second opinion pathologic assessment. Importantly, the key elements of the Mohs procedure, including excision and evaluation of the frozen section slides, must be done entirely by the Mohs surgeon, who must act as both surgeon and pathologist. None of these functions may be delegated to another physician, such as a pathologist. It is considered good medical care that before, during, or after Mohs surgery, paraffin sections from an area that is not part of the Mohs procedure, may be sent for evaluation as a second opinion consultation to a pathologist without affecting the integrity of the Mohs procedure.

Page 3 of 6 APPENDICES Appendix 1 Second Opinion Consultation is Required during Treatment of Melanoma When melanoma is treated by Mohs, a second opinion consultation is required in a higher percentage of cases. This reflects the requisite high standard of care for melanoma treatment given the higher associated risks. Commonly, the central melanoma area may be sent for paraffin serial sections to assess the depth of invasion, or a slide(s) on a given stage may be sent for pathologic consultation. Additionally, when Mohs surgery is used as a treatment for melanoma in situ, Kinonen & Reddy (2010; citing Dawn, Dawn & Miller 2007) recommend: A final margin can then be taken from around the tumor and sent for paraffin sections to confirm the initial frozen section margin assessment. 1 Further Tissue Processing is Required In complex Mohs cases, tumors may be unusually aggressive, deep, or otherwise histologically unusual. In these cases, paraffin section processing and pathologic analysis may be required for evaluation of these tumors unusual histologic features: Unusually aggressive tumors would include poorly differentiated tumors. Deep tumors include tumors penetrating into bone and requiring processing of the same, which cannot be done with frozen sections. Special stains with paraffin sections may be required for confirmation of clear margins for rare and uncommon nonmelanoma tumors that are treated with Mohs surgery, such as Merkel cell carcinoma (CK-20), or dermatofibrosarcoma protuberans (CD-34). Histologically unusual tumors may also include those with a diffuse inflammatory infiltrate that makes interpretation of frozen sections unreliable. Interdisciplinary management may be needed to improve cure rate for certain tumors with a potentially high metastatic rate or high likelihood of local recurrence. For instance, for dermatofibrosarcoma protuberans, an algorithm has been reported that combines Mohs and paraffin section evaluation (Kimmel Z, Ratner D, Kim JY, Wayne JD, Rademaker AW, Alam M. Peripheral excision margins for dermatofibrosarcoma protuberans: a meta-analysis of spatial data. Ann Surg Oncol. 2007 Jul; 14(7): 2113-20). 1 Dawn ME, Dawn AG, Miller SJ (2007). Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg. 2007; 33:395-402. Cited in Kinonen & Reddy 2010. Kinonen C, Reddy VB (2010). The Skin. In J Taxy, A Husain, & A Montag (Eds.) Biopsy Interpretation: The Frozen Section. (p. 270-302) New York: Wolters Kluwer.

Page 4 of 6 Confirmation of New Diagnosis is Required Prior to the initiation of Mohs surgery, a biopsy specimen is obtained to establish diagnosis. The original biopsy specimen may not be representative of the entire tumor. Thus, when removing a tumor, a more representative section may occur for which second opinion consultation is required. Obtaining such a consultation does not negate the Mohs procedure. Collision lesions can also occur. In a typical collision lesion, two unrelated tumors may be physically proximal or even overlapping. The prior biopsy specimen leading to initiation of Mohs may have diagnosed one of these tumors, but not detected the adjacent tumor. For instance, a basal cell carcinoma undergoing Mohs may be proximal to an amelanotic nodular melanoma, which may require different treatment. When suspecting a collision lesion, paraffin sections should be sent for pathologic examination. Staging or Grading is Required Very aggressive tumors may require additional therapy. On occasion, this may become apparent during Mohs surgery, when extensive tumor invasion is detected for the first time. For instance, during Mohs surgery tissue debulking, it may become apparent that perineural, vascular, or lymphatic invasion is present. Such invasion may in turn suggest the need for additional radiation therapy, lymph node biopsy or dissection, or enrollment in a chemotherapy protocol. For the Mohs procedure to be valid, the physician must remove the tumor tissue and examine it pathologically by frozen section to confirm margin negativity. Additional confirmation of staging or grading may be appropriately obtained by a dermatopathology consultation or by paraffin sections sent for pathologic examination without invalidating the Mohs procedure. A Second Opinion is Required The decision to send paraffin sections for pathologic examination should be guided by: the acceptable standard of care; good medical practice; the need to avoid patient harm; and the need to ensure patient benefit. In addition to the above itemized situations, special circumstances may arise when it is necessary and in the patient s best interest to send a paraffin section out for evaluation. The use of consultations and second opinions are longstanding patient safety measures employed by all medical specialties. No policy, procedure or coverage determination should be in place that jeopardizes patient safety by limiting the use of a second opinion or consultation services.

Page 5 of 6 When Frozen Section Interpretation is Not Sufficient It is generally accepted that frozen sections are, in some instances, of lesser quality than paraffin sections. In 1991, the College of American Pathologists' Q-study probe found that for frozen sections, there existed a 4.2% deferral of diagnosis rate and discordance with paraffin section diagnosis of 1.7% (Novis, Gebhardt & Zarbo 1996, as cited in Montag 2010). 2 This deferral refers to instances in which frozen sections are of insufficient quality for diagnosis, and in which tissue is sent for paraffin section and pathologic analysis. In these instances, it is undeniably the standard of care to obtain pathologic consultation. If, despite proper processing, frozen sections cannot be interpreted, recuts and restaining, or other adjustments in the frozen section laboratory, may be sufficient to remedy this problem. If such further frozen section processing is impractical or insufficient, paraffin sections may appropriately be sent for second opinion consultation. 2 Novis DA, Gebhardt GN, Zarbo RJ (1996). College of American Pathologists, Interinstitutional comparisons of frozen section consultation in small hospitals: a College of American Pathologists Q probes study of 18,532 frozen section consultation diagnoses in 233 small hospitals. Arch Pathol Lab Med. 1996; 120(12): 1087-1093. Cited in Montag 2010. Montag AG. (2010) The Frozen Section: Historical Background and Quality Assurance. In J Taxy, A Husain, & A Montag (Eds.) Biopsy Interpretation: The Frozen Section. (p. 1-11)New York: Wolters Kluwer.

Page 6 of 6 Appendix 2 Meeting Criteria for Mohs Surgery According to the 2011 CPT Coding Definitions under Mohs Micrographic Surgery, the following description is given: Mohs Micrographic Surgery...requires a single physician to act in two integrated but separate and distinct capacities: surgeon and pathologist. If either of these responsibilities is delegated to another physician who reports the services separately, these codes should not be reported [emphasis added]. 3 As per communication from members of the committee of the American College of Mohs Surgery that drafted the above CPT description of Mohs Surgery around 1982 when the codes were changed from 17300-17302 to 17304-17310 (Richard Bennett, personal communication, 2011), the definition was never meant to exclude paraffin section pathologic examination under circumstances of difficulty in interpretation of frozen sections. Rather, it was meant to exclude a pathologist from collaborating with a surgeon to perform Mohs surgery. A pathology consultation with a paraffin section for a small percentage of the slides examined by the Mohs surgeon should not be viewed in the same light. The integrity of the Mohs surgery is not affected so long as all aspects inherent to Mohs surgery are performed under the supervision of the Mohs surgeon as the surgeon and pathologist: tumor resection, slide creation, slide interpretation, issue of a written report and medical decision making based upon the results of the interpretation. The use of a consultation in conjunction with Mohs surgery supplements the work of Mohs surgery; it does not replace the work of Mohs surgery. The operational rule is that a pathologist should neither prepare nor read the frozen section slides at the time of Mohs surgery. This definition does not preclude a pathologist from reading a paraffin section slide at some later point as part of a second opinion consultation; there would be no delegation of responsibility in this instance. 3 Current Procedural Terminology: Standard Edition (2011), 4 th Ed. Chicago: American Medical Association. p. 58.